Connect Biopharma Holdings Limited Ordinary Shares
$1.28
Market Cap
$80.61M
Shares Outstanding
63.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 3, 2025
Round Lot
100
Locale
US
Day Open
$1.25
Day High
$1.32
Day Low
$1.25
Volume
1.28M
VWAP
$1.29
Prev Close
$1.29
Transactions
--
Acc. Volume
--
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Connect Biopharma Holdings Limited Ordinary Shares (CNTB) closed the 2026-09-18 session at $1.28, down 0.78% versus the previous close (-0.01). The stock opened at $1.25 and traded between $1.25 and $1.32 during that session. Session trading volume was 1.3M shares. The volume-weighted average price (VWAP) is $1.29.
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Connect Biopharma Holdings Limited Ordinary Shares has a market capitalization of $80.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CNTB is listed on the XNAS exchange. The company employs approximately 64 people. Connect Biopharma Holdings Limited Ordinary Shares is headquartered in SAN DIEGO, CA. The recorded listing date is 2025-09-03.
On this page you can find market CNTB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.